In Process, Unpublished STS/ACC TVT Registry Manuscripts

Similar documents
In Process, Unpublished STS/ACC TVT Registry Manuscripts

ACTION REGISTRY New Old ID# ID #

In Process, Unpublished NCDR Manuscripts

In Process, Unpublished NCDR Manuscripts

Indication, Timing, Assessment and Update on TAVI

After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients?

7 th Conference of Transcatheter Heart Valve Therapies

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

Debate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI

Aortic Stenosis: Background

Published Manuscripts Based in the STS/ACC TVT Registry

TAVI and TAVR: Radical and Revolutionary: The Newest Insights for the CV Community and a Panel Discussion

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Mechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute

Aortic Valve Stenosis and TAVR: Putting it all together.

Published Manuscripts Based in the STS/ACC TVT Registry

Valve Disease. Valve Surgery. Total Volume. In 2016, Cleveland Clinic surgeons performed 3039 valve surgeries.

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

Worldwide rheumatic fever is the most common cause of valve disease. In industrialized areas, valvular disease of old age predominates

Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY)

Transcatheter Valve Replacement: Current State in 2017

Valve Disease. Valve Surgery. In 2015, Cleveland Clinic surgeons performed 2943 valve surgeries.

Incidence, Predictors, and Outcomes of Prosthesis-Patient Mismatch in 62,125 TAVR Patients. An STS/ACC TVT Registry Report

TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy

National Cardiovascular Data Registry

Aortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter

Valvular Intervention

Is it a business for the cardiac surgeon?

Outcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era

Prof. Dr. Thomas Walther. TAVI in ascending aorta / aortic root dilatation

Published Manuscripts Based in the STS/ACC TVT Registry

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

TAVI Versus Suturless Valve In Intermediate Risk Patients

TAVR in patients with. End-Stage CKD or in Renal Replacement Therapy:

Vinod H. Thourani, MD, FACC, FACS

Is Stroke Frequency Declining?

Cardiac Valve/Structural Therapies

Le TAVI pour tout le monde?

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France

Neal Kleiman, MD Houston Methodist DeBakey Heart and Vascular Institute

TAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology

30-Day Outcomes Following Implantation of a Repositionable Self-Expanding Aortic Bioprosthesis: First Report From the FORWARD Study

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School

Introducing the COAPT Trial

TAVR for low-risk patients in 2017: not so fast.

TAVR in Intermediate Risk Populations /Optimizing Systems for TAVR

TAVR in 2020: What is Next!!!!

Should We Reconsider using Anticoagulation for Biological Tissue Valves

Transcatheter Therapies For Aortic Valve Disease. March 2017 Brian Whisenant MD

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

Transcatheter Aortic Valve Implantation. SSVQ November 23, 2012 Centre Mont-Royal 15:40

Euro Heart Survey New Programme Sentinel Registry Transcatheter Valve Treatment (TCVT) Carlo Di Mario, London, UK President EAPCI

HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY?

THE PERCUTANEOUS MANAGEMENT OF VALVULAR HEART DISEASE DR JOHN RAWLINS CONSULTANT INTERVENTIONAL CARDIOLOGIST UNIVERSITY HOSPITAL SOUTHAMPTON

Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR)

TAVR: Review of the Robust Data from Randomized Trials

TAVR SPRING 2017 The evolution of TAVR

Aortic Stenosis: Open vs TAVR vs Nothing

Update interventional Cardiology Hans Rickli St.Gallen

Transcatheter Aortic Valve Replacement

TAVR: Intermediate Risk Patients

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

PERCUTANEOUS STRUCTURAL UPDATES TAVR WATCHMAN(LEFT ATRIAL APPENDAGE OCCLUDERS) MITRACLIP PARAVALVULAR LEAK REPAIRS ASD/PFO CLOSURES VALVULOPLASTIES

Prosthesis-Patient Mismatch in High Risk Patients with Severe Aortic Stenosis in a Randomized Trial of a Self-Expanding Prosthesis

e Corrado Tamburino, MD, PhD

How to Avoid Prosthesis-Patient Mismatch

The FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation

MITRAL STENOSIS: MANY FLAVORS Rheumatic and Calcification. Rheumatic Mitral Stenosis 76yo male

Mitral Valve Disease, When to Intervene

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data

Transcatheter Heart Valve Therapy

Strokes After TAVR Reasons for Declining Frequency

Severe left ventricular dysfunction and valvular heart disease: should we operate?

Transcatheter Heart Valve Procedures

Putting together a structural heart program from the imagers perspective

Valvular Heart Disease Transcatheter Valve Therapies. October 2016 Brian Whisenant MD

Appropriate Patient Selection or Healthcare Rationing? Lessons from Surgical Aortic Valve Replacement in The PARTNER I Trial Wilson Y.

One Year Outcomes from the STS/ACC Transcatheter Valve Therapy (TVT) Registry

THE VALVE CLINIC VALVE CONFERENCE

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?

Five-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe Aortic Stenosis: The PARTNER Trial

TAVI: Nouveaux Horizons

Emergency TAVI: Does It Exist? Is the Risk Higher?

Assessment and Preparation of Patients with TAVI. Rob Tanzola Associate Professor, Queen s University

Transcatheter Mitral Valve Replacement How Close Are We?

Welcome 17 Michigan TAVR Participating Hospitals!

Australia and New Zealand Source Registry Edwards Sapien Aortic Valve 30 day Outcomes

The Future of Medicine. Who to TAVR? Azeem Latib MD EMO-GVM Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy

Is it Time for a National Network of Valve Centers? MICHAEL MACK, MD BAYLOR SCOTT & WHITE HEALTH

Hardware in the Chest - From VADs to Valves

Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI)

Case Presentations TAVR: The Good Bad and The Ugly

Rapid deployment aortic valve replacement for the treatment of severe aortic stenosis in high risk patients. Β. Κόλλιας, Σ. Ματιάτου, Δ. Αγγουράς.

TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con

Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD

TAVI Implantation: Rapid Pacing, Pre and Post Dilatation

Transcription:

In Process, Unpublished STS/ACC TVT Registry Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript development, or submitted to a journal for review/publication. RPA ID Title Lead Author Email 101 Transcatheter AVR for the Treatment of High Risk Patients with Bicuspid Aortic Valve Disease. A Report of the STS/ACC TVT Registry j.matthew.brennan@duke.edu; 127 A Characterization of the Incidence and Predictors of Paravalvular Regurgitation (PVL) and its Impact on Outcomes: A Study of the STS/ACC Transcatheter Valve Therapy (TVT) Database sanwaruddin@gmail.com 133 The Effect of TAVR on the Need for Repeat Hospitalization holmes.david@mayo.edu 161 Relationship of Body Mass Index (BMI) with Outcomes After Transcatheter Aortic Valve replacement (TAVR) abhishek.sharma@downstate.edu 191 Stroke and Transient Ischemic Attack Among Patients with Extracranial Carotid Artery Disease Undergoing Transcatheter Aortic Valve Replacement schuyler.jones@dm.duke.edu 1

200 Transcatheter Aortic Valve Replacement Using a Self-Expanding Bioprosthesis: First Report From the STS/ACC Transcatheter Valve Therapy Registry jpopma@bidmc.harvard.edu 114 Impact of the Presence of Coronary Artery Disease and the Revascularization on Outcomes of Patients Undergoing Trans-catheter Aortic Valve Replacement: Insights from STS/ACC TVT Registry htankazyan@llu.edu 186 Effects of Fragmentation of Post-Procedural Care on Outcomes after TAVR aw100@duke.edu 36 Acute Kidney Injury in Transcatheter Aortic Valve Replacement: Can We Reduce the Risk? CHB8D@hscmail.mcc.virginia.edu 57 The Outcomes of Transcatheter Aortic Valve Replacement in Patients with End-Stage Renal Disease mszerlip@gmail.com 98 Outcomes of patients with elevated pulmonary artery pressure undergoing TAVR hmartinjulien@gmail.com 110 Incidence, Predictors, and Outcomes of Vascular Complications and Bleeding Events in real-world patients undergoing TAVR in the U.S.: Insights from the STS/ACC TVT Registry matthew.sherwood@duke.edu 2

117 The Use of Red Blood Cell Transfusion and Outcomes after TAVR: Insights from the STS/ACC TVT Registry matthew.sherwood@duke.edu 156 Incidence and Outcomes of Patients Requiring Surgical Bail-Out during Transcatheter Aortic Valve Replacement from the NCDR STS/ACC TVT Registry andres.pineda@msmc.com 236 Analysis of transcatheter aortic valve replacement in those with or without a previous mitral valve prosthesis. vthoura@emory.edu 240 Development of a Risk Prediction Model for 1-Year Mortality after Surgical vs. Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis suzanne.baron@gmail.com 244 Effect of smoking on clinical and health status outcomes after transcatheter aortic valve replacement (TAVR) mqintar@saint-lukes.org 256 Clinical Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Mitral Valve-in-Valve) and Surgical Rings (Mitral Valve-in-Ring) in the United States mayraguerrero@me.com 260 Failure to Rescue in Transcatheter Aortic Valve Replacement muath.bishawi@duke.edu 3

267 The Effect of Age and Frailty on Survival in Patients Undergoing TAVR skiani@emory.edu 361 Individualized Risk Prediction for Intermediate and High Risk Patients with Aortic Valve Stenosis Considering SAVR or TAVR in the United States j.matthew.brennan@duke.edu 194 Incidence and Risk Factors of Aborted Procedures and Emergent Conversion to Surgery During Elective TAVR aw100@duke.edu 285 Change in Mitral Valve Gradient Following Mitraclip Repair and Correlation to 30-day and 1 year outcomes lowie.assche@northwestern.edu 296 Effects of pulmonary arterial hypertension on mitral clip outcomes ral-bawardy@mgh.harvard.edu 28 In-Hospital and Long-Term Costs Associated with Peri-Procedural Complications in Patients Treated with Transcatheter Aortic Valve Replacement: Results from the TVT Registry dcohen@saint-lukes.org 113 Reported Health Status Before and After TAVR sva1024@yahoo.com 4

170 AATS Guideline: TAVI in the hybrid operating room, hybrid catheterization suite, or catheterization laboratory; is there a difference? greason.kevin@mayo.edu 180 Incidence of new dialysis post-tavr based on pre-procedural CKD stage; Reviewers james.w.hansen@lahey.org 209 Practice patterns and clinical outcomes when cardiac arrest or cardiogenic shock precedes Transcatheter Aortic Valve replacement Luke.I.Masha@uth.tmc.edu 241 Estimating the risk of mortality in aortic valve disease treatment: assessment for bias in non-randomized treatment comparisons roland.matsouaka@duke.edu 258 Pre- versus post-procedure clinical event rates and associated healthcare resource utilization in patients who undergo commercial MitraClip placement for severe mitral regurgitation morgan.cox@duke.edu 263 Incidence and Risk Factors for Early Stroke after Transcatheter Aortic Valve Replacement: Insights from the STS-ACC TVT Registry hudedc@ccf.org 270 Development of a 30 day mortality risk model for pts w/tavr suz.v.arnold@gmail.com 5

291 Racial Disparities in Structural Heart Disease in the TVT Registry holmes.david@mayo.edu 332 Predicting Thirty-day Readmissions after Transcatheter Aortic Valve Replacement carlos.sanchez@ohiohealth.com 253 Outcomes of trans-catheter aortic valve replacement (TAVR) in patients with mixed aortic valve disease bhardwajb@health.missouri.edu 353 Sex-Based Differences in Outcomes Afer Transcatheter Repair of Mitral Regurgitation with the MitraClip System pedrovillablanca@hotmail.com 357 The Association Between Driving Distance and Outcomes after TAVR morgan.cox@duke.edu 371 Learning curve for transcatheter mitral repair: Insights from the STS/ACC TVT Registry achhatriwalla@saint-lukes.org 374 Understanding Out of Hospital 30 Day Mortality after TAVR: An Analysis of the STS/TVT Registry sanwaruddin@gmail.com 6

399 Impact of Short-Term Complications of TAVR on Outcomes. Results from the STS/ACC Transcatheter Valve Therapy Registry. dcohen@saint-lukes.org 350 The Effect of Obesity on Outcomes in Patients Undergoing MitraClip- Insights from the TVT-NCDR registry Javier.valle@ucdenver.edu 438 STS/ACC TVT Registry 2018 Update from Three Modules john.carroll@ucdenver.edu 439 The TAVR Volume Outcome Relationship: A report from the STS/ACC TVT Registry sreekanth.vemulapalli@duke.edu 406 "Improving Data Completeness and Expanding Available Data Elements in the TVT Registry through the use of Electronic Health Record Based Data: Linking the TVT Registry and PCORnet" sreekanth.vemulapalli@duke.edu 7